Phase 2 Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with migraine with aura (a type of migraine that includes warning symptoms like visual disturbances before the headache)
- You have had at least one migraine with aura per month for the 3 months before joining the trial
- You have not been taking any regular migraine prevention medication for at least 1 month before joining
- If you are a woman who could become pregnant, you must be using a reliable form of contraception starting at least 3 months before the trial and continuing for 1 month after it ends
- You are willing and able to sign a consent form agreeing to take part
- You are covered by French Social Security (confirm with trial site)
Who may not be able to join:
- You have a known allergy or sensitivity to the drug amiloride
- You have high potassium levels in your blood (above 5.5 mmol/l)
- You are currently taking certain other water tablets (diuretics) or potassium supplements that can raise potassium levels
- Your kidneys are not working well enough (below a certain level of function)
- You have severe liver disease
- You are taking certain other medications that may interact with amiloride, including lithium, some blood pressure medicines, ciclosporin, tacrolimus, or certain other drugs (confirm with trial site for the full list)
- You are over 75 years old and have a history of heart or kidney problems
- The trial team feels you may have difficulty following the study procedures
- You are currently pregnant or breastfeeding
- You are under legal guardianship or a similar form of legal protection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michel LANTERI-MINET, Dr, Centre Hospitalier Universitaire de Nice
Phone: 04 92 03 76 46
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of attacks with aura, with or without headache.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.